Technical Analysis for HEM - Hemostemix Inc.

Grade Last Price % Change Price Change
F 0.050 0.00% 0.000
HEM closed unchanged on Friday, April 19, 2024, on 2.88 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -9.09%

   Recent Intraday Alerts

Alert Time
3x Volume Pace about 19 hours ago
2x Volume Pace about 24 hours ago
1.5x Volume Pace about 24 hours ago
New 52 Week Low about 24 hours ago
Gapped Down (Full) 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hemostemix Inc is a Canada-based clinical-stage biotechnology company. The Company's principal business is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions, including critical limb ischemia (CLI). The Company's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of CLI. ACP-01 is in a Phase II clinical trial in Canada, South Africa and the United States. The Company also focuses on developing other cell products, such as bone cell precursors (BCPs), myocardial cell precursors (MCPs) and neural cell precursors (NCPs). It operates in Canada and Israel. The Company has approximately 2,200 square foot research and manufacturing facility in Ness Ziona, Israel. Hemostemix Limited is the subsidiary of the Company.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Nature Clinic Biotechnology Biology Therapy Clinical Trial Bone Hypertension Stem Cells Cell Biology Cell Products Cell Therapy Manufacturing Facility

Is HEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.21
52 Week Low 0.05
Average Volume 38,605
200-Day Moving Average 0.097
50-Day Moving Average 0.074
20-Day Moving Average 0.062
10-Day Moving Average 0.057
Average True Range 0.005
RSI (14) 33.33
ADX 22.28
+DI 21.236
-DI 44.533
Chandelier Exit (Long, 3 ATRs) 0.061
Chandelier Exit (Short, 3 ATRs) 0.064
Upper Bollinger Bands 0.076
Lower Bollinger Band 0.047
Percent B (%b) 0.1
BandWidth 46.179
MACD Line -0.006
MACD Signal Line -0.006
MACD Histogram -0.0007
Fundamentals Value
Market Cap 38.76 Million
Num Shares 775 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -2.38
Price-to-Sales 0.00
Price-to-Book 27.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.050
Resistance 3 (R3) 0.050 0.050 0.050
Resistance 2 (R2) 0.050 0.050 0.050 0.050
Resistance 1 (R1) 0.050 0.050 0.050 0.050 0.050
Pivot Point 0.050 0.050 0.050 0.050 0.050
Support 1 (S1) 0.050 0.050 0.050 0.050 0.050
Support 2 (S2) 0.050 0.050 0.050 0.050
Support 3 (S3) 0.050 0.050 0.050
Support 4 (S4) 0.050